Abstract:Abstract The function of the yes-associated protein (YAP) transcription co-activator remains an enigma since reports indicate that YAP either acts as an oncogene or enhances apoptosis. In this study, we found that YAP expression occurs in 51% of human hepatocellular carcinoma (HCC) biopsies while phosphorylated YAP (pYAP) expression occurs in 33% of Grade II and III HCCs. In addition, we found that YAP and p53 expression/ nuclear translocation increase in chemo-treated HepG2 cells. In chemo-treated HepG2 cells transfected with WT-YAP or blank (control), the chemosensitivity of the HepG2 + WT-YAP cells increases compared to HepG2+blank cells. In chemo-treated HepG2 cells transfected with Flag-S94A (TEAD binding domain mutant), Flag-W1W2 (WW domain mutant), or blank (control), the chemosensitivity and p53 expression/ nuclear translocation of the HepG2+Flag-S94A cells and HepG2+Flag-W1W2 cells decrease compared to HepG2+blank cells. In chemo-treated HepG2 cells transfected with Flag-5SA-S94A or Flag-5SA-W1W2, the chemosensitivity and p53 expression/ nuclear translocation of the HepG2+Flag-5SA-S94A cells and HepG2+Flag-5SA-W1W2 cells increase again compared to HepG2+Flag-S94A cells or HepG2+Flag-W1W2 cells respectively. These results indicate that YAP promotes chemosensitivity by modulating p53 during chemo-treatment, and YAP-modulated p53 activity requires the TEAD binding domain and the WW domain. In summary, our data indicate that YAP functions as a tumor-suppressor that enhances apoptosis by modulating p53 activity during chemo-treatment. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 826. doi:1538-7445.AM2012-826

Yap/Tead-Mediated Transcription Controls Cellular Senescence

TEAD Mediates YAP-dependent Gene Induction and Growth Control

YAP upregulates AMPKα1 to induce cancer cell senescence

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation.

Both Tead-Binding and Ww Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein

SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

YAP Enhances Autophagic Flux to Promote Breast Cancer Cell Survival in Response to Nutrient Deprivation.

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

YAP 1‐ LATS 2 Feedback Loop Dictates Senescent or Malignant Cell Fate to Maintain Tissue Homeostasis

Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.

Sequential Targeting of YAP1 and P21 Enhances the Elimination of Senescent Cells Induced by the BET Inhibitor JQ1.

YAP Modulates TGF-β1-induced Simultaneous Apoptosis and EMT Through Upregulation of the EGF Receptor

A New Regulatory Mechanism Between P53 and YAP Crosstalk by SIRT1 Mediated Deacetylation to Regulate Cell Cycle and Apoptosis in A549 Cell Lines

Abstract 4516: Inhibiting YAP activity in cancers by targeted degradation of TEAD

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

YAP prevents premature senescence of astrocytes and cognitive decline of Alzheimer's disease through regulating CDK6 signaling

Releasing YAP Dysfunction‐caused Replicative Toxicity Rejuvenates Mesenchymal Stem Cells

YPEL3 expression induces cellular senescence via the Hippo signaling pathway in human breast cancer cells

Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis

Abstract 826: Yes-associated Protein Increases Hepatocellular Carcinoma Chemosensitivity by Modulating P53

Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.